BPC-157 for Tendon Injuries: Mechanisms, Risks, and Reality

BPC-157 for Tendon Injuries: Mechanisms, Risks, and Reality
If you hang around fitness forums or biohacking circles, you’ve probably heard whispers (or more like shouting) about BPC-157.  

It’s a peptide touted as the next big breakthrough for injury recovery, and honestly, unlike many other products being pushed out there, it shows a lot of promise.

However, there’s a lot to unpack before you go looking for it on Amazon.


What Are Peptides, Like BPC-157?

Peptides are amino acid messengers that instruct our cells to repair, grow, rest, and perform countless other functions. 

Specifically, BPC-157 was first discovered in human stomach juice in the 1990s, and since then, it has become a hot topic because it appears to help animals heal faster.

Inside the body, BPC-157 interacts with several of our natural healing systems.  Just read this review, and you'll be ready to buy a lifetime supply.
 
Some of the actions include:
  • Boost blood vessel growth (angiogenesis): This increases the blood supply and nutrient delivery to damaged areas.
  • Activate nitric oxide (NO) pathways: Nitric oxide helps relax blood vessels, reduce inflammation, and signal tissue repair.
  • Protect cells from oxidative stress: That means it might help limit damage from unstable molecules that can harm tissues.
Scientists have also noticed that BPC-157 can influence neurotransmitters like dopamine and serotonin, which may be why it shows some effects in studies on stress and depression.


Why It's Not Ready for Prime Time

The mechanisms and numerous anecdotes surrounding BPC-157 sound promising; unfortunately, almost all of the research has been limited to animal studies (primarily rats and rabbits) and in vitro tendon analyses.
 
Human evidence for BPC-157 is scarce and of poor quality.  It has been conducted on limited sample sizes, without blinding, and typically by clinics that profit from selling BCP-157.

We really don’t know anything about dosing, frequency, duration, or potential negative side effects, other than stories from people who have tried it.

If you’re saying to yourself, rats, rabbits, and gym bro approval are good enough for me, the biggest issue is that BPC-157 is not FDA-approved for human use.  That doesn't mean it's illegal, but there is no oversight on purity, dosing, or safety.  
 
So, unfortunately, even if you want to give it a go, you'll be heading into the wild west of little to no regulation. 

It’s also worth mentioning that WADA and all major anti-doping bodies ban it, so if you’re a competitive athlete at any level, using it risks career-impacting consequences, which is a hard gamble for unproven benefits.
 
And because it's injected into the injury site for soft tissue injuries, supplementing it is far more complicated than just swallowing a pill, and introduces the risk for infection, swelling, and contamination. 
 
On a positive note, it appears to be safe.  Several rodent studies used massive doses and found no negative effects on the internal organs.
 
However, there is a potential for harm that needs further investigation.
  1. Any compound that promotes angiogenesis and cell proliferation raises theoretical concerns about tumor support — not because BPC-157 causes cancer, but because it may remove natural brakes on abnormal tissue growth.
  2. An increased formation of blood vessels and disorganized cell growth are classic signs related to advanced tendinopathies.  Since BPC-157 promotes these changes, there’s a chance that, even despite the suppression of pain, it could potentially advance the pathology related to overuse tendon injuries.
So maybe BPC-157 does spark tissue building, but so does growth hormone.  The major difference here is that the risk profile of HGH is well established.


A Clinicians Perspective

Before sitting down to write this, I talked with one of my PT colleagues about it.  His observations from patients who have used it are usually some short-term relief, but the effects often wane over time.

And together we decided that if our wife or kids (or random folks reading newsletters on the internet) asked whether they should use BPC-157, my answer would be, "No, there’s too much unknown at this point."

However, being honest, if I were facing a 50% tendon tear that didn’t seem to be improving, I’d certainly be tempted.

That doesn’t mean it’s right. It’s just human nature that risk tolerance tends to bend when pain is present.

However, until robust human trials emerge, the evidence-based pillars of recovery remain as progressive loading, a solid foundation of sleep and nutrition, and patience.

Originally published as Movement #278

Featured Products